Similar articles

• Clinical enigmas of paraneoplastic neurologic disorders.

  Posner JB, Dalmau J. Posner JB, et al. Clin Neurol Neurosurg. 1995 Feb;97(1):61-70. doi: 10.1016/0303-8467(95)00009-9. Clin Neurol Neurosurg. 1995. PMID: 7788978 Review. No abstract available.
• [Antineuron antibodies and paraneoplastic neurological syndromes].

  Benyahia B, Carpentier AF, Delattre JY. Benyahia B, et al. Rev Neurol (Paris). 2003 Apr;159(4):463-5. Rev Neurol (Paris). 2003. PMID: 12773880 Review. French. No abstract available.
• Paraneoplastic syndromes.

  Posner JB, Furneaux HM. Posner JB, et al. Res Publ Assoc Res Nerv Ment Dis. 1990;68:187-219. Res Publ Assoc Res Nerv Ment Dis. 1990. PMID: 2183311 Review. No abstract available.
• [Discussion: immunologic nervous system diseases investigated from the molecular level].

  Takamori M, Arimura K, Inutsuka T, Kira J, Kusunoki S. Takamori M, et al. Nihon Naika Gakkai Zasshi. 1998 Apr 10;87(4):697-714. Nihon Naika Gakkai Zasshi. 1998. PMID: 9627480 Japanese. No abstract available.
• Immune modulation of paraneoplastic neurologic disorders.

  Graus F, Delattre JY. Graus F, et al. Clin Neurol Neurosurg. 1995 Feb;97(1):112-6. doi: 10.1016/0303-8467(95)00008-8. Clin Neurol Neurosurg. 1995. PMID: 7788966 Review. No abstract available.